WASHINGTON, May 30 -- Office Of The United States Trade Representative has issued a notice called: Request for Comments Regarding Foreign Nations Freeloading on American-Financed Innovation.
The notice was published in the Federal Register on May 30 by Jennifer Thornton, General Counsel, Office of the United States Trade Representative.
Summary: Pursuant to the Executive Order titled Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients, USTR invites comments from interested parties regarding any act, policy, or practice that may be unreasonable or discriminatory and that has the effect of forcing American patients to pay for a disproportionate amount of global pharmaceutical research and development, including by ...